Introduction
Nitric oxide (NO) is now recognized as an important mediator of functions in a variety of physiological systems (Moncada et al., 1992) , including the reproductive system (Yallampalli et al., 1993 (Yallampalli et al., , 1994 (Yallampalli et al., , 1998 Shukovski and Tsafriri, 1994, Chatterjee et al., 1996) . Endogenous NO is synthesized from the enzymatic conversion of L-arginine to L-citrulline by NO synthase (NOS) (Moncada et al., 1992) . There are two major classes of NOS: calcium/calmodulin-dependent constitutive isoforms and calcium/calmodulin-independent inducible isoforms (Fostermann et al., 1991) . The constitutive isoforms (NOS I and III) mediate a large number of biological functions including vascular tone, platelet aggregation and regulation of synaptic transmission. The inducible isoform (NOS II) is induced in a variety of cells, including macrophages, smooth muscle cells and hepatocytes, by exposure to cytokines including interferon-γ, tumour necrosis factor-α, interleukin-1β and bacterial lipopolysaccharides (Hibbs et al., 1992; Hunley et al., 1995) . These reactions produce large amounts of NO which contribute to the host defence, as well as killing the cells in the region (Kroneke et al., 1991) . Studies have demonstrated that elevated NO concentrations can reduce ATP levels in cells by inhibiting their ATP-generating ability (Hibbs et al., 1990; Moncada et al., 1991) . This mechanism of NO-induced cytostasis and cytotoxicity includes direct inhibition of mitochondrial respiration and DNA synthesis and interactions with peroxinitrite and hydroxyl radical (Beckman et al., 1990) . Implantation may be considered as a sequence of biochemical and physical interactions between the embryo and the uterus. Fertilized ova continue to divide and reach blastocyst stage before implantation can occur. In rodents, the stage of embryo development and uterine receptivity are synchronized for successful implantation indicating a defined window for implantation (Fleming et al., 1989) . Embryos fail to implant if either the uterine receptivity or the development of embryos is impaired. Since NO at higher concentrations is cytotoxic, it could alter either the development of embryos or uterine receptivity and thus implantation.
Clinical studies have shown that conditions such as endometriosis and reproductive tract infection (male and female) are associated with infertility (Haney et al., 1983; Barratt et al., 1990) . In these pathological conditions there is an increase in the number and activation status of macrophages in peritoneal fluid and in the reproductive tract (Halme et al., 1983 (Halme et al., , 1987 Hills et al., 1988) . These activated cells could produce large quantities of NO in addition to other effector molecules. There are no reports either on the effects of NO on embryo development or on the level of NO production which may be elevated in the situations mentioned above. Therefore, in the present study we evaluated the effect of NO on mouse embryo development by culturing 2-4-cell mouse embryos in the presence of diethylenetriamine/NO (DETA/NO), an NO donor, and monitoring their development. The second part of the study evaluated the effect of NO on embryo implantation in mice, by continuously infusing mated mice with DETA/NO and determining the implantation rate.
Materials and methods
Animals B 6 C 3 F 1 female mice at 4 weeks of age were superovulated by i.p. injection of 5 IU of pregnant mare's serum gonadotrophin (PMSG; Sigma, St Louis, MO, USA), followed (42-48 h) by an i.p. injection of 5 IU human chorionic gonadotrophin (HCG; Sigma). They were then placed into a cage with male mice (B 6 C 3 F 1 ). Mating was assessed after 12-14 h and was confirmed by the presence of spermatozoa in vaginal flushings. Mated mice were used to study either embryo development in vitro or implantation in vivo. The use of the mice in these studies was according to the guidelines approved by the animal care and use committee of the University of Texas Medical Branch at Galveston.
Embryo development study
Following mating, mice were killed on day 2 by cervical dislocation and the oviducts were flushed in Dulbecco's phosphate-buffered saline (PBS; Gibco, Grand Island, NY, USA) with a 1 ml syringe or pipette to collect 2-4-cell embryos (Hogan et al., 1986) . The embryos were cultured in 100 ml drops of Ham's F10 (Gibco) medium (with or without supplements) containing 0.3% of bovine serum albumin (BSA; Sigma), under mineral oil in a 5% carbon dioxide incubator with 95% humidity. All embryos were monitored daily and scored for stage of development. Various concentrations of DETA/NO (Alexis Corporation, San Diego, CA, USA) (0.001, 0.01, 0.1 and 1 mM) and DETA (Sigma) (0.1 and 1 mM) were prepared using Ham's F10 medium-0.3% BSA. The solutions containing DETA/NO were freshly prepared and replaced every 24 h throughout the study.
Implantation study B 6 C 3 F 1 female mice were superovulated using the same protocol as above. Mated mice were implanted s.c. (day 1 of pregnancy) with miniosmotic pumps (Alzet ® model 2001; 1 ml/h, 7 days; Alza corporation, Pala Alto, CA, USA) containing either saline or different concentrations (0.2, 0.4 and 0.8 mM) of DETA/NO or DETA to deliver a daily dose of 5, 10 or 20 µmol per animal. The animals were killed on day 6 and the uterus was checked for implantation sites. Mice with at least one implantation site were considered to be pregnant.
Statistics
Statistical analyses were performed using χ 2 -test, and P Ͻ 0.05 was considered significant. Table I summarizes the percentage of embryos that attained at least morula stage by day 4 of incubation, in the presence of different concentrations of DETA/NO. In control media, 94.5% of the embryos developed to at least morula stage. With concentrations of 0.001 and 0.01 mM of DETA/NO, there were no significant differences in the embryo development when compared with the control group. However, none of the embryos progressed beyond the 4-cell stage (0/20 and 0/40) when DETA/NO was used at concentrations of 0.1 and 1 mM (P Ͻ 0.001), respectively (Figure 1 ). The NO donor therefore appears to inhibit embryo development at concentrations of 504 ജ 0.1 mM. Since no embryo degeneration was observed, the effect of the NO donor appeared to be related to the blockage of development rather than toxicity to the embryos. To investigate whether the inhibitory effect of NO donor on embryo development was due to NO or to DETA, we used two different methods: first the medium containing DETA/NO (0.1 mM solution) was preincubated for 48 h before embryo culture. This preincubation presumably allows NO to be released from DETA/NO prior to incubation with embryos, leaving only DETA in the medium. In the second method, the medium was supplemented with 0.1 and 1 mM concentrations of DETA without NO. The results, summarized in Table II, show that there was no significant effect upon the rate of embryo development caused by incubation with either preincubated DETA/NO or with DETA only. These results confirm that the inhibitory effects of the NO donor, DETA/ NO, on the development of embryos were due to NO and not to DETA. The effects of the infusion of different doses of NO on the implantation of embryos in mice are presented in Figures 2  and 3 . The data summarized in Figure 3 show that no significant differences in implantation rate were observed in mice receiving either 5 or 10 µmol/mouse/day of DETA/NO or DETA, when compared with the control group. However, when the dose was increased to 20 µmol/mouse/day, no implantation sites were observed (P Ͻ 0.05) in DETA/NO group. Animals receiving the equivalent dose of DETA had implantations sites which were not significantly different in number compared with the saline-treated controls. These results suggest that NO rather than DETA/NO inhibited implantation of mouse embryos. 
Results

Discussion
In this study we show for the first time that NO at higher doses inhibits embryo development in vitro and implantation in vivo. The effects of the NO donor, DETA/NO, were specific for NO, but not for DETA and were dose-dependent. These studies suggest that excess NO generation mediated by inflammatory factors in reproductive tissues may inhibit embryo development and implantation and thus lead to infertility.
Nitric oxide is an important mediator of many biological functions, and has beneficial effects when generated within physiological limits. When generated in large quantities for longer periods of time, as during infection and immunological reactions, NO can cause cytostatic and cytotoxic effects. Several clinical studies have shown that pathological conditions including endometriosis and infection of the reproductive tract (male and female) were associated with infertility (Haney et al., 1983; Barratt et al., 1990) . In both of these conditions there are increases in the number of activated macrophages in the pelvis and in the reproductive tract (Halme et al., 1983 (Halme et al., , 1987 Hills et al., 1988) and these activated cells could produce large quantities of NO. It is well recognized that infection and cytokines induce the expression of NOS II in a variety of cells and this isoform of NOS generates considerable amounts of NO for prolonged periods of time (Moncada and Higgs, 1991; Moncada et al., 1992; Hunley et al., 1995) . These high concentrations of NO in the reproductive tract could potentially inhibit embryo development and implantation in vivo suggesting a mechanism for infection-associated infertility.
In the present study, mouse embryos were cultured in different concentrations of NO donor. At higher concentrations (0.1 and 1 mM), NO had an inhibitory effect on embryo development. Control experiments, in which embryos were cultured with DETA alone or with preincubated DETA/NO, demonstrated that the inhibitory effects of DETA/NO were due to NO, not to DETA. This study also demonstrates that NO inhibited implantation rate in vivo. No implantation sites were observed in mice receiving 20 µmol/day of DETA/NO, whereas with DETA alone at this dose the implantation rate was not affected. The dose of DETA/NO (20 µmol/day/mouse) that caused inhibitory effects on implantation in vivo was similar to the dose (1 mM) that inhibited embryo development in vitro. These studies suggest that pathological situations, e.g. endometriosis and reproductive tract infection, could lead to the production of excess NO which could inhibit embryo development and implantation, leading to infertility. This effect of NO is somewhat different from its postulated roles in early pregnancy including local vasodilation, control of trophoblastic invasion and the prevention of fetal rejection (Ramsay et al., 1996) . These suggested roles were based primarily on the observed relatively high levels of NO synthase activity in villous trophoblast during the first trimester. However, from these studies it is not possible to assess the role of NO on embryo development and implantation. In addition, our data suggest that NO effects on embryo development occur perhaps when the embryos are still in the Fallopian tube rather than in the uterus. Although the mechanisms of NO-induced impairment of embryo growth are unclear, it does not appear to involve cytotoxicity since embryo development was arrested at the 4-cell stage and no embryo degeneration was seen. Further studies are required in the human to place these animal studies in the context of human early embryo development.
It is difficult to determine how much NO was liberated from DETA/NO in our in-vivo studies and what concentration of NO actually reached the target organs, e.g. Fallopian tubes. In the studies by Ramsay et al. (1996) , first trimester villi were reported to generate 2-29 nmol L-citrulline/min/g protein during normal human pregnancy, and a similar NOS activity (13.7 Ϯ 3.0 nmol citrulline/min/g protein) in myocardium of patients with dilated cardiomyopathy has been reported (deBelder et al., 1993) . The local NO concentration in the tissues of animals receiving NO donor cannot be assessed with precision since NO is a shortlived molecule and no precise methods are available at the present time for its direct measurements in tissues. Therefore, we speculate that the concentration of NO in reproductive tract tissues in mice infused with DETA/NO (20 µmol/day/animals) may have been greater than physiological levels and therefore caused the inhibition of embryo development and implantation.
Nitric oxide can also interfere with fertility through NOassociated decreases in sperm motility (Rosselli et al., 1995; Weinberg et al., 1995; Nobunaga et al., 1996) , possibly by a mechanism involving cellular respiration (Weinberg et al., 1995) . Furthermore, recent reports have demonstrated the presence of constitutive NOS (NOS III) in several female reproductive organs (Chatterjee et al., 1996) , where its expression is differentially regulated during the reproductive cycle, suggesting that NO may be involved in the modulation of female reproductive functions. In addition, other studies have supported 506 an involvement of NO in ovarian physiology (Shukovski and Tsafriri, 1994; Van-Voorhis et al., 1994) since inhibition of NO diminished ovulatory efficiency (Shukovski and Tsafriri, 1994) . Thus, NO may play a role in the regulation of fertility. It appears that a deficiency in NO could interfere with ovulation mechanisms (Shukovski and Tsafriri, 1994) , whereas excess NO could interfere with embryo development and implantation. Further studies are needed to determine which mechanisms are involved.
We have previously demonstrated that NO is generated in various reproductive tract tissues in the female rat (Yallampalli et al., 1993 (Yallampalli et al., , 1994 (Yallampalli et al., , 1998 . NOS III is abundantly expressed in the luminal epithelial cells as well as in smooth muscle layers of both oviduct and uterus (Chatterjee et al., 1996) . Expression of NOS II but not NOS III is increased in the uterus during pregnancy and by bacterial lipopolysaccharide treatment in non-pregnant rats (C. Yallampalli et al., unpublished observations) . The NO generating system has also been demonstrated in the human reproductive tract (Buhimschi et al. 1995; Telfer et al., 1995 Telfer et al., , 1997 . Furthermore, NO appears to play a role in a variety of reproductive functions (Rosselli, 1997 ). These studies demonstrate that the female reproductive tract is capable of NO generation and NOS expression. Both NO generation and NOS expression are influenced by steroid hormones, inflammatory agents and pregnancy (Yallampalli et al., 1994 (Yallampalli et al., , 1995 Dong et al., 1996) . Alterations in the NOS expression and/or NO production in these tissues could directly affect the development of embryos present in the lumen, especially during early stages of pregnancy.
In conclusion, we provide evidence for the first time that NO causes inhibition of mouse embryo development in vitro and implantation in vivo in a dose-dependent manner. Based on our findings and those of others (Haney et al., 1983; Barrat et al., 1990; Beckman et al., 1990; Hibbs et al., 1990; Moncada and Higgs, 1991) , we speculate that infection and endometriosis associated with infertility could be related to decreased embryo development and implantation caused through the production of excess NO in the reproductive tract.
